A groundbreaking drug , retatrutide, is creating considerable buzz within the Oz weight management community. Created by the company, this dual GIP and GLP-1 receptor appears to deliver more significant results than present therapies. Initial medical studies have shown remarkable reductions in body weight , indicating the for a innovative strategy